![Servier - Moved by you..]({"type":"image" , "src" : "/sda/112354/JournalAd-Servier-5s.gif"})
References
- Therrien J, Dore A, Gersony W, Iserin L, Liberthson R, Meijboom F, Colman JM, Oechslin E, Taylor D, Perloff J, Somerville J, Webb GD. CCS Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease. Part I. Can J Cardiol 2001; 17(9): 940–59.
- Prokselj K, Kozelj M, Zadnik V, Podnar T. Echocardio-graphic characteristics of secundum-type atrial septal defects in adult patients: implications for percutaneous closure usingAmplatzer septal occluders. J Am Soc Echocardiogr 2004; 17(11): 1167–72.
- Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 2002; 39(11): 1836–44.
- Chessa M, Carminati, Butera G, Bini RM, Drago M, Rosti L, Giamberti A, Pome G, Bossone E, Frigiola A. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002; 39(6): 1061–5.
- Perry YY, Triedman JK, Gauvreau K, Lock JE, Jenkins KJ. Sudden death in patients after transcatheter device implan-tation for congenital heart disease. Am J Cardiol 2000; 85(8): 992–5.
- Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Car-diol 2005; 45(8): 1213–8.
- Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to min-imize future risk. Catheter Cardiovasc Interv 2004; 63(4): 496–502.
- Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004; 43(2): 302–9.
- Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, GerberM, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT. Prevention of Infective Endocarditis. Guidelines from the American Heart Association. A Guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 115: published online April 19, 2007.
- Van Mieghem N, Daenen W, Budts W How a left-to-right shunt may protect against haemodynamic deterioration in restrictive cardiomyopathy. Acta Cardiol 2005; 60(3): 337–340.
- Ando G, Tomai F, Gioffre PA. Left ventricular decompres-sion through a patent foramen ovale in a patient with hyper-trophic cardiomyopathy: a case report. Cardiovasc Ultrasound 2004; 2: 2.
![A worldwide pioneer in biotechnology.]({"type":"image" , "src" : "/sda/112403/JournalAd-Amgen-MPU.png"})
![A bold vision to stop cardiovascular disease from being a leading cause of death.]({"type":"image" , "src" : "/sda/112402/JournalAd-amarin.jpg"})